Trials / Conditions / Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
4 registered clinical trials studyying Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) NCT02973997 | Academic and Community Cancer Research United | Phase 2 |
| Completed | Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer NCT02393690 | Academic and Community Cancer Research United | Phase 2 |
| Active Not Recruiting | Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer NCT02152995 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be R NCT00381641 | National Cancer Institute (NCI) | Phase 2 |